Guardant Health, Inc. (GH)

USD 32.36

(-7.12%)

Operating Expenses Summary of Guardant Health, Inc.

  • Guardant Health, Inc.'s latest annual operating expenses in 2023 was 901.62 Million USD , up 7.38% from previous year.
  • Guardant Health, Inc.'s latest quarterly operating expenses in 2024 Q2 was 205.43 Million USD , up 1.26% from previous quarter.
  • Guardant Health, Inc. reported a annual operating expenses of 837.59 Million USD in annual operating expenses 2022, up 26.57% from previous year.
  • Guardant Health, Inc. reported a annual operating expenses of 661.74 Million USD in annual operating expenses 2021, up 47.33% from previous year.
  • Guardant Health, Inc. reported a quarterly operating expenses of 202.87 Million USD for 2024 Q1, down -53.22% from previous quarter.
  • Guardant Health, Inc. reported a quarterly operating expenses of 198.95 Million USD for 2023 Q3, down -1.95% from previous quarter.

Annual Operating Expenses Chart of Guardant Health, Inc. (2023 - 2016)

Historical Annual Operating Expenses of Guardant Health, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 901.62 Million USD 7.38%
2022 837.59 Million USD 26.57%
2021 661.74 Million USD 47.33%
2020 449.14 Million USD 98.71%
2019 226.02 Million USD 61.02%
2018 140.37 Million USD 48.01%
2017 94.83 Million USD 101.9%
2016 46.97 Million USD 0.0%

Peer Operating Expenses Comparison of Guardant Health, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD -505.143%
Prenetics Global Limited 60.73 Million USD -1384.477%
Star Equity Holdings, Inc. 16.27 Million USD -5440.935%
CareDx, Inc 277.76 Million USD -224.595%
Exact Sciences Corporation 2.06 Billion USD 56.243%
Exagen Inc. 52.29 Million USD -1624.171%
Inotiv, Inc. 246.9 Million USD -265.172%
Biodesix, Inc. 77.41 Million USD -1064.599%
BioNexus Gene Lab Corp. 3.92 Million USD -22882.443%
Precipio, Inc. 13.63 Million USD -6511.094%
iSpecimen Inc. 16.27 Million USD -5439.143%
Natera, Inc. 938.98 Million USD 3.979%
Aspira Women's Health Inc. 24.11 Million USD -3638.994%
Standard BioTools Inc. 113.48 Million USD -694.457%
23andMe Holding Co. 420.73 Million USD -114.298%
Castle Biosciences, Inc. 242.78 Million USD -271.369%
Personalis, Inc. 128.14 Million USD -603.6%
Aclaris Therapeutics, Inc. 110.52 Million USD -715.762%
Applied DNA Sciences, Inc. 16.48 Million USD -5368.771%
OpGen, Inc. 30.65 Million USD -2840.903%
T2 Biosystems, Inc. 41.49 Million USD -2072.895%
Myriad Genetics, Inc. 600.1 Million USD -50.245%
ICON Public Limited Company 755.64 Million USD -19.318%
NeoGenomics, Inc. 341.25 Million USD -164.21%
Star Equity Holdings, Inc. 16.27 Million USD -5440.935%
IDEXX Laboratories, Inc. 1.09 Billion USD 17.498%
RadNet, Inc. 268.87 Million USD -235.326%
MDxHealth SA 71.25 Million USD -1165.326%
Psychemedics Corporation 11.33 Million USD -7855.011%
Illumina, Inc. 3.81 Billion USD 76.354%
Check-Cap Ltd. 19.28 Million USD -4574.76%
Twist Bioscience Corporation 354.18 Million USD -154.566%
DarioHealth Corp. 62.17 Million USD -1350.181%
Fulgent Genetics, Inc. 171.9 Million USD -424.485%
Sera Prognostics, Inc. 39.91 Million USD -2158.739%
ENDRA Life Sciences Inc. 10.52 Million USD -8469.943%
OPKO Health, Inc. 574.68 Million USD -56.889%
Medpace Holdings, Inc. 187.68 Million USD -380.403%
Neogen Corporation 405.23 Million USD -122.492%
Intelligent Bio Solutions Inc. 11.7 Million USD -7600.371%
Prenetics Global Limited 60.73 Million USD -1384.477%
Mainz Biomed B.V. 27.15 Million USD -3220.357%
bioAffinity Technologies, Inc. 8.76 Million USD -10186.79%
Trinity Biotech plc 46.49 Million USD -1839.178%
Neuronetics, Inc. 82.25 Million USD -996.076%
Sotera Health Company 300.46 Million USD -200.074%
bioAffinity Technologies, Inc. 8.76 Million USD -10186.79%